title: Diagnostic value of immune cholesterol as a marker for atherosclerosis.
abstract: BACKGROUND
  The serum of patients with coronary atherosclerosis contains circulating immune complexes including low-density lipoproteins (LDLs). We have developed a technique for the evaluation of LDL content in circulating immune complexes by measuring total cholesterol levels in polyethylene glycol precipitates (immune cholesterol). In the present study, the value of immune cholesterol in the diagnosis of atherosclerosis was compared with that of other laboratory parameters, such as total cholesterol levels, triglycerides, LDL cholesterol, high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins B and A-1.
  
  
  METHODS
  Immune cholesterol and the other parameters were determined in blood samples from 200 patients with documented coronary and extracoronary atherosclerosis. Coronary atherosclerosis was assessed by coronary angiography; stenoses in the aortic arch and branches and in lower-limb arteries were evaluated by angiography and ultrasonography.
  
  
  RESULTS
  Only immune cholesterol and the ratio of apolipoprotein B to apolipoprotein A-1 correlated significantly with the severity of coronary atherosclerosis. The accuracy of the diagnosis of coronary atherosclerosis by immune cholesterol was 78%, considerably higher than that of other laboratory parameters. Use of a combined parameter consisting of immune cholesterol, LDL cholesterol, and the patient's age increased the diagnostic accuracy to 81%. A high level of immune cholesterol is characteristic not only of coronary atherosclerosis but also of extracoronary atherosclerosis. The sensitivity, specificity and accuracy of the diagnosis of extracoronary atherosclerosis were even higher than those for coronary atherosclerosis.
  
  
  CONCLUSIONS
  Immune cholesterol may be employed as a novel marker in the diagnosis of advanced atherosclerosis.
authors: Institute of Experimental Cardiology, Cardiology Research Center, Moscow, Russia.
authors: A N
authors: AN
authors: Orekhov
authors: O S
authors: OS
authors: Kalenich
authors: V V
authors: VV
authors: Tertov
authors: N V
authors: NV
authors: Perova
authors: Novikov IyD
authors: A A
authors: AA
authors: Lyakishev
authors: A D
authors: AD
authors: Deev
authors: Ruda MYa
mesh_terms: D000328:Adult; D001054:Apolipoproteins A / Q000276:immunology; D001055:Apolipoproteins B / Q000276:immunology; D002784:Cholesterol / Q000276:immunology*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000276:immunology; D005260:Female; D006801:Humans; D007105:Immune Complex Diseases / Q000175:diagnosis* / Q000276:immunology; D017270:Lipoprotein(a) / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D001054:Apolipoproteins A; D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D017270:Lipoprotein(a); D002784:Cholesterol